Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Intestinal Microbiome
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1423662

The gut microbiota intervenes in glucose tolerance and inflammation by regulating the biosynthesis of taurodeoxycholic acid and carnosine

Provisionally accepted
  • Beijing University of Chinese Medicine, Beijing, China

The final, formatted version of the article will be published soon.

    Objective: This study aims to investigate the pathogenesis of hyperglycemia and its associated vasculopathy by using multiomics analyses in diabetes and impaired glucose tolerance. Methods: In this study, we conducted a comprehensive analysis of the metagenomic sequencing data of diabetes. Subsequently, participants diagnosed with impaired glucose tolerance (IGT), and healthy subjects, were recruited for fecal and blood sample collection. The dysbiosis of the gut microbiota (GM) and its associated metabolites were analyzed using 16S rDNA sequencing and liquid chromatograph mass spectrometry, respectively. The regulation of gene and protein expression was evaluated through RNA sequencing and data-independent acquisition technology, respectively. The specific mechanism by which GM dysbiosis affects hyperglycemia and its related vasculopathy was investigated using real-time qPCR, Western blotting, and enzyme-linked immunosorbent assay techniques in HepG2 cells and neutrophils. Results: Based on the published data, the key alterable genera in the GM associated with diabetes were identified. The GM metabolites taurodeoxycholate (TUDCA) and carnosine were both found to be decreased, which in turn regulated the expression of proteins in plasma and mRNAs in neutrophils. Insulin-like growth factor-binding protein 3 and interleukin-6 proteins were found to be suppressed by TUDCA and carnosine (CARN) in HepG2 cells and neutrophils. Conclusion: Dysbiosis of the GM occurred throughout the entire progression from IGT to diabetes, characterized by an increase in Blautia and a decrease in Faecalibacterium, leading to reduced levels of TUDCA and CARN, which promoted the expression of insulin-like growth factor-binding protein 3 and interleukin-6, contributing to the development of hyperglycemia and associated vasculopathy.

    Keywords: diabetes, Gut Microbiota, Impaired glucose tolerance, Metabolomics, mRNA sequencing, Proteomics

    Received: 26 Apr 2024; Accepted: 15 Jul 2024.

    Copyright: © 2024 Zhen, Zhang, Li, Zhou, Cai, Huang and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Yali Zhou, Beijing University of Chinese Medicine, Beijing, China
    Yanan Cai, Beijing University of Chinese Medicine, Beijing, China
    Guangrui Huang, Beijing University of Chinese Medicine, Beijing, China
    Anlong Xu, Beijing University of Chinese Medicine, Beijing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.